Company Filing History:
3 out of 767 
2 out of 1,029 
1 out of 370 
Years Active: 2015-2024
Title: Martin Kelp: Innovator in Intraocular Lens Injection Technology
Introduction
Martin Kelp is a distinguished inventor based in Berlin, Germany. He has made significant contributions to the field of medical technology, particularly in the development of injectors for intraocular lenses. With a total of 7 patents to his name, Kelp's innovations have advanced the way intraocular lenses are inserted into the eye.
Latest Patents
Kelp's latest patents include an injector designed for inserting an intraocular lens into a capsular bag of the eye. This injector features a first piston and a second piston, allowing for precise displacement of the lens. The injector body has a proximal end facing away from the opening and a distal end. The first piston is directed toward the opening and is configured to contact and displace the intraocular lens. The second piston is operable from outside of the injector, and both pistons are longitudinally displaceable along the injector axis. Additionally, Kelp has developed another injector that includes a handle for carrying along a front and a rear displacement mechanism, enhancing the functionality and ease of use for medical professionals.
Career Highlights
Throughout his career, Martin Kelp has worked with notable companies in the medical technology sector. He has been associated with Carl Zeiss Meditec AG and Karl Storz & Co. KG, where he has contributed to the development of innovative medical devices. His work has been instrumental in improving surgical procedures and patient outcomes.
Collaborations
Kelp has collaborated with talented professionals in his field, including Hadi Moein and Stefan Oginski. These collaborations have fostered an environment of innovation and have led to the successful development of advanced medical technologies.
Conclusion
Martin Kelp's contributions to the field of intraocular lens injection technology have made a lasting impact on medical practices. His innovative patents and collaborations with industry leaders continue to shape the future of ophthalmic surgery.